# OnCo record nct03937154 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03937154/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03937154", "NCT03937154" ;
  schema:name "Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer"@en ;
  schema:alternateName "PROCLAIM"@en ;
  schema:description "A phase 3 trial of Romiplostim in non-small-cell lung cancer, run by Amgen, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03937154/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03937154> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-02-26" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/romiplostim/> ;
  onco:companies <https://onco.cc/companies/amgen/> .